Clinical trial Recruiting at 3 sites Interventional Ages 65 and up

Improving medication management for elderly surgical patients

Official title: Implementation and Impact of Multidisciplinary Medication Review in Surgery Departments on Medication Management of Elderly Patients

Run by Centre Hospitalier Universitaire de Nīmes · NCT03827031 · Data updated 2026-11-12

This study tests whether having a pharmacist and a doctor work together can help older surgical patients manage their medications more safely and effectively.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment297 (estimated)
SponsorCentre Hospitalier Universitaire de Nīmes
Academic / other
Locations4 sites (Grenoble and 3 other locations)
StatusRecruiting
StartedJuly 18, 2022
Main results expectedJuly 2027
Study endsJuly 2027
Registry record updatedAugust 20, 2025
Trial IDNCT03827031 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are elderly patients aged 65 and older who are hospitalized in surgery departments and are taking at least five medications.

Probably not a fit

Patients receiving palliative care or those participating in other interventional studies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact of having a clinical pharmacist and a general practitioner work together in surgery departments to enhance medication management for elderly patients. The approach involves conducting multidisciplinary medication reviews and providing follow-up support from community pharmacists. The goal is to ensure safer and more effective medication use among patients aged 65 and older who are on multiple medications. By focusing on this vulnerable population, the study aims to address the complexities of medication management in a surgical context.

Why it matters

Potential benefit: If successful, this approach could lead to improved medication safety and health outcomes for elderly patients undergoing surgery.

How similar studies have gone: Previous studies have shown that multidisciplinary approaches to medication management can improve patient outcomes, suggesting potential success for this study.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The patient (or their representative) has given his consent and signed the consent form.
* The patient is affiliated to a health insurance programme.
* The patient is at least 65 years old (≥) treated by at least (≥) five medications for at least (≥) 6 months
* The patient is available for a follow-up of 3 months.
* The patient is hospitalized in the surgery department.
* Patient with a Trivalle score greater than or equal to 2 (≥).
* Patient living in a nursing home or going back home after hospitalization.

Exclusion Criteria:

* The subject is participating in another category I interventional study.
* The subject is in an exclusion period determined by another study.
* The subject is under safeguard of justice.
* It is not possible to give the patient (or his/her trusted-person) informed information.
* Palliative care

Where it's running

  • CHU de Montpellier
    Montpellier, France
    Recruiting
  • Nimes University Hospital
    Nîmes, France
    Recruiting
  • CHU de Toulouse
    Toulouse, France
    Recruiting
  • Chu de Grenoble
    Grenoble, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.